A delay in the FDA decision for NT-501 could leave those with macular telangiectasia (MacTel) without any form of treatment ...
NT-501 is an investigational ocular implant that utilizes an encapsulated cell-based delivery system to deliver continuous ciliary neurotrophic factor.
GlobalData on MSN5d
FDA delays priority review of Neurotech’s eye cell therapy implantThe US regulatory agency has pushed the PDUFA date by three months to 18 March 2025 to “allow for more time to review ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback